Our Senior Managing Director Greg Garfield caught up with Ken Dropiewski last week on the Investor Insights podcast to discuss KCK Medtech's target investment profile and the outlook for 2025 in MedTech. Follow the link below to watch the entire interview: https://lnkd.in/gSHpx4tN
KCK Medtech
Venture Capital and Private Equity Principals
Campbell, California 1,176 followers
About us
KCK MedTech is an evergreen investment fund. Our flexible capital and operationally experienced team enable us to help build significant intrinsic value in companies. Portfolio Companies: -Earlens -Cerapedics -Sight Sciences -RefleXion Medical -NeuroPace -Mainstay Medical -Lungpacer Medical -Sonex Health -Intuity Medical -Aerin Medical -Applaud Medical
- Website
-
https://www.kckmedtech.com/
External link for KCK Medtech
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- Campbell, California
- Type
- Privately Held
- Founded
- 2015
Locations
-
Primary
Get directions
368 E Campbell Ave
Suite 200
Campbell, California 95008, US
Employees at KCK Medtech
Updates
-
Congratulations Revelle Aesthetics, Inc., a KCK Medtech portfolio company, for expanding access to their groundbreaking Avéli® cellulite reduction treatment by joining forces with Tiger Aesthetics. Thank you Caroline Van Hove and the entire leadership team for your work in building such a meaningful technology and company.
We’re excited to announce the acquisition of Revelle Aesthetics, makers of the Avéli® cellulite reduction device. The Avéli device is the only single-use disposable device that enables visualization and targeted release of the specific septa causing the cellulite dimples. The minimally invasive procedure is performed in-office under local anesthesia and can be administered by both licensed and trained physicians, as well as mid-level providers in many states. With the Revelle acquisition, we can now provide a comprehensive and differentiated suite of combination options for lower body rejuvenation, inclusive of Avéli for cellulite, Viality™ for enhanced viability fat transfer, and the forthcoming alloCLAE™ and dermaCLAE™ structural adipose fillers to augment volume in aesthetic body procedures. We're excited to continue leading the way in regenerative and aesthetic solutions. Learn more about the acquisition here: https://lnkd.in/eTyCQBA9 #TigerAestheticsMedical #Avéli #RevelleAesthetics
-